← Back to Search

Behavioral Intervention

Cognitive Training for Parkinson's Disease (HOBSCOTCH-PD Trial)

N/A

Recruiting

Led By Elaine T Kiriakopoulos, MD, MPH, MSc

Research Sponsored by Dartmouth-Hitchcock Medical Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Diagnosis of Parkinson's Disease per participant's provider

Literate, English-speaking with grade 12 or equivalent in education

Must not have

Cognitive dysfunction that precludes participation in giving informed consent

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline (pre-hobscotch-pd) and post-hobscotch-pd, approximately 9 weeks later.

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to see if a home-based self-management program for epilepsy, called HOBSCOTCH, can be adapted for people with Parkinson's Disease. Participants will attend virtual sessions with a coach

Who is the study for?

This trial is for people with Parkinson's Disease who are experiencing cognitive impairment or memory loss. Participants will engage in a program called HOBSCOTCH-PD, which involves nine one-hour virtual sessions aimed at improving self-management and quality of life.

What is being tested?

The study tests whether the HOBSCOTCH program, originally designed for epilepsy patients, can be adapted to help those with Parkinson's Disease. It measures if participants see an improvement in their quality of life and cognitive functions after completing the program.

What are the potential side effects?

Since this intervention is non-medical and focuses on self-management and cognitive training through coaching sessions, there are no direct medical side effects associated with it.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

My doctor diagnosed me with Parkinson's Disease.

Select...

I can read and speak English and have completed at least 12 years of education.

Select...

I experience problems with my memory or thinking.

Select...

I am between 30 and 75 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I am able to understand and give consent for my treatment.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline (pre-hobscotch-pd) and post-hobscotch-pd, approximately 9 weeks later.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline (pre-hobscotch-pd) and post-hobscotch-pd, approximately 9 weeks later.

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline (pre-hobscotch-pd) and post-hobscotch-pd, approximately 9 weeks later. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Change in quality of life as measured by comparing PDQ-39 (Parkinson's Disease Questionnaire) scores pre- and post-HOBSCOTCH-PD intervention.

Change in subjective cognition as measured by comparing Neuro-QOL Item Bank v2.0 Cognitive Function scores pre- and post-HOBSCOTCH-PD intervention.

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: PD Participant with Cognitive DysfunctionExperimental Treatment1 Intervention

Participants will receive the HOBSCOTCH-PD intervention consisting of 1:1 sessions delivered once per week including: * 1 pre-HOBSCOTCH Session (on webcam or by phone) * 1 educational session (on webcam) * 6 HOBSCOTCH intervention sessions (webcam or phone) * 1 wrap-up session (webcam or phone)

0 / 5Eligibility criteria met